Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Titel:
Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): follow-up analysis of a randomised, phase 3 study
Auteur:
Richardson, Paul G Perrot, Aurore San-Miguel, Jesus Beksac, Meral Spicka, Ivan Leleu, Xavier Schjesvold, Fredrik Moreau, Philippe Dimopoulos, Meletios A Huang, Jeffrey Shang-Yi Minarik, Jiri Cavo, Michele Prince, H Miles Malinge, Laure Dubin, Franck van de Velde, Helgi Anderson, Kenneth C